Author:
Beier Jutta,Chanez Pascal,Martinot Jean-Benoit,Schreurs A.J.M.,Tkáčová Ružena,Bao Weibin,Jack Damon,Higgins Mark
Subject
Pharmacology (medical),Biochemistry (medical),Pulmonary and Respiratory Medicine
Reference23 articles.
1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report. Bethseda: National Heart, Lung, and Blood Institute; April 2001: Updated 2005. GOLD website 〈www.goldcopd.com〉.
2. Efficacy and duration of salmeterol powder inhalation in protecting against exercise-induced bronchoconstriction;Schaanning;Ann Allergy Asthma Immunol,1996
3. Salmeterol xinafoate. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease;Brogden;Drugs,1991
4. Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma;Wallin;Thorax,1993
5. The duration of action of inhaled formoterol dry powder;Quebe-Fehling;Br J Clin Pract,1996
Cited by
68 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献